47 results on '"Takanashi, Hisanori"'
Search Results
2. Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes
3. Oral administration of MA-2029, a novel selective and competitive motilin receptor antagonist, inhibits motilin-induced intestinal contractions and visceral pain in rabbits
4. Effects of Oral Mitemcinal (GM-611), Erythromycin, EM-574 and Cisapride on Gastric Emptying in Conscious Rhesus Monkeys
5. Effects of Motilin and Mitemcinal (GM-611) on Gastrointestinal Contractile Activity in Rhesus Monkeys In Vivo and In Vitro
6. Design and Synthesis of Novel Pure Motilin Antagonists
7. Characterization of Multinuclear Hepatocytes Induced in Rats by Mitemcinal (GM-611), an Erythromycin Derivative
8. MITEMCINAL (GM-611), AN ORALLY ACTIVE MOTILIN RECEPTOR AGONIST, IMPROVES DELAYED GASTRIC EMPTYING IN A CANINE MODEL OF DIABETIC GASTROPARESIS
9. Assessment of the carcinogenic potential of mitemcinal (GM-611): Increased incidence of malignant lymphoma in a rat carcinogenicity study
10. ORAL MITEMCINAL (GM-611), AN ERYTHROMYCIN-DERIVED PROKINETIC, ACCELERATES NORMAL AND EXPERIMENTALLY DELAYED GASTRIC EMPTYING IN CONSCIOUS DOGS
11. Hypotensive mechanism of [Leu13]motilin in dogs in vivo and in vitro
12. Design and Synthesis of Novel Tetra-Peptide Motilin Agonists
13. Motilides: A long and winding road
14. Effects of Oral Mitemcinal (GM-611), Erythromycin, EM-574 and Cisapride on Gastric Emptying in Conscious Rhesus Monkeys
15. ORAL MITEMCINAL (GM‐611), AN ERYTHROMYCIN‐DERIVED PROKINETIC, ACCELERATES NORMAL AND EXPERIMENTALLY DELAYED GASTRIC EMPTYING IN CONSCIOUS DOGS
16. HEMODYNAMIC AND ELECTROPHYSIOLOGICAL EFFECTS OF MITEMCINAL (GM-611), A NOVEL PROKINETIC AGENT DERIVED FROM ERYTHROMYCIN IN A HALOTHANE-ANESTHETIZED CANINE MODEL
17. PRECLINICAL ELECTROPHYSIOLOGY ASSAYS OF MITEMCINAL (GM-611), A NOVEL PROKINETIC AGENT DERIVED FROM ERYTHROMYCIN
18. Effects of Mitemcinal (GM-611), an Acid-Resistant Nonpeptide Motilin Receptor Agonist, on the Gastrointestinal Contractile Activity in Conscious Dogs
19. In vitro Pharmacological Characterization of Mitemcinal (GM-611), the First Acid-Resistant Non-Peptide Motilin Receptor Agonist, in Smooth Muscle of Rabbit Small Intestine
20. Design and Synthesis of Motilin Antagonists Derived from the [1−4] Fragment of Porcine Motilin
21. Design and Synthesis of N-terminal Cyclic Motilin Partial Peptides: A Novel Pure Motilin Antagonist.
22. Contractile mechanism of GM-611 on gastrointestinal motility in conscious dogs
23. Structure-Activity Study of Intact Porcine Motilin.
24. Effect of dual inhibition of 5-alpha-reductase and aromatase on spontaneously developed canine prostatic hypertrophy
25. Vasodilative mechanism of [Leu13]-motilin in canine isolated mesenteric artery
26. Effects of motilin receptor agonists on gastrointestinal motility and hemodynamics in dogs.
27. Differential effects of buspirone on gastric motility and emptying in rats.
28. Macrolide-type motilin receptor agonists: Acid-stable 12-O-methyl-8,9-anhydroerythromycin A 6,9-hemiacetals
29. Motilin antagonistic activity of GM-I09 in the smooth muscle of the rabbit small intestine
30. GM-611, an acid-stablc erythromycin A derivative, induces contractions in the rabbit small intestine via the motiiin receptor
31. Macrolide-type motilin receptor agonists: Assessment of the biological value of the 2′- and 4″-hydroxyl groups of acid-stable 8,9-anhydroerythromycin A 6,9-hemiacetals
32. Potent, acid-stable and orally active macrolide-type motilin receptor agonists, GM-611 and the derivatives
33. Effects of GM-611, a novel erythromycin derivative, on gastrointestinal motility and gastric emptying in conscious Rhesus monkeys.
34. GM-611, a novel erythromycin derivative, acts as a motilin agonist in the rabbit duodenum.
35. Effects of GM-611, a novel erythromycin derivative, on gastrointestinal motility and gastric emptying in dogs.
36. Comparative studies with 15(R)-15-methylprostaglandin E2 (arbaprostil) in rat femoral arterial preparations in vivo and in vitro
37. Protective Effects of Arbaprostil against Indomethacin-Induced Gastric Lesions in Rats: Significance of Maintained Gastric Blood Row
38. Protective Effects of Arbaprostil against Indomethacin-Induced Gastric Lesions in Rats: Significance of Maintained Gastric Blood Flow.
39. Effects of Cisapride on Gastrointestinal Motor Activity and Gastric Emptying of Disopyramide.
40. Acid-Promoted Epimerization of Arbaprostil, 15(R)-15-Methylprostaglandin E2, Elicits Gastric Antisecretory Activities in Rats
41. Gastric Antisecretory Activity of 15(R)-15-Methylprostaglandin E2, Arbaprostil, in Dogs
42. In vitro Pharmacological Characterization of Mitemcinal (GM-611), the First Acid-Resistant Non-Peptide Motilin Receptor Agonist, in Smooth Muscle of Rabbit Small Intestine.
43. Receptive relaxation of the canine stomach.
44. Atropine-resistant neural regulation of gastric blood flow in rats: Comparison of vagal electric stimulation and 2-deoxy-D-glucose stimulation
45. P-49 - Vasodilative mechanism of [Leu13]-motilin in canine isolated mesenteric artery
46. O-88) - Atropine-resistant neural regulation of gastric blood flow in rats: Comparison of vagal electric stimulation and 2-deoxy-D-glucose stimulation
47. Design and synthesis of motilin antagonists derived from the [1-4] fragment of porcine motilin.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.